Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

Introduction: Primary resistance to immune checkpoint inhibitors (ICI) is observed in routine clinical practice. We sought to determine factors predictive of primary resistance to ICI monotherapy, defined by the Society for Immunotherapy of Cancer (SITC) as progression within 6 months of ICI treatme...

Full description

Bibliographic Details
Main Authors: Yiqing Huang, Joseph J. Zhao, Yu Yang Soon, Adrian Kee, Sen Hee Tay, Folefac Aminkeng, Yvonne Ang, Alvin S. C. Wong, Lavina D. Bharwani, Boon Cher Goh, Ross A. Soo
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
primary resistance
immune checkpoint inhibitor
non-small-cell lung cancer
Online Access:https://www.mdpi.com/2072-6694/15/10/2733

Internet

https://www.mdpi.com/2072-6694/15/10/2733

Similar Items